Browse the evidence

Bariatric surgery has the greatest degree of expected weight loss, at around 20%-30% at 1 year.

Bariatric surgery may be the most effective option for patients needing significant weight loss.

Significant reductions in diastolic BP (-1.5 mm Hg) and systolic BP (-1.1 mm Hg) were observed.

Semaglutide may help lower blood pressure in adults.

Metabolic adaptation hinders the efficacy of obesity management strategies.

Understanding metabolic adaptation can help practitioners develop more effective obesity management strategies.

Bariatric surgery is a highly effective intervention to induce weight loss with durability over 10 or more years.

Bariatric surgery can be considered a long-term solution for significant weight loss.

There is a distinct correlation between type 2 diabetes status and the likelihood of heart failure.

Recognizing this correlation can guide healthcare providers in monitoring and managing heart health in diabetic patients.

Weight gain within the first 6 months was associated with increased risk of HbA1c >7.5% and subsequent cardiovascular disease (CVD) with a hazard ratio (HR) of 1.03.

Clinicians should monitor weight changes in T2D patients as it may impact glycemic control and cardiovascular health.

Weight gain at 1 year was associated with increased risk of HbA1c >7.5% (HR 1.05) and kidney disease (HR 1.03).

Weight management is crucial for T2D patients to prevent worsening glycemic control and kidney disease.

Weight gain was associated with lower diabetes treatment satisfaction.

Healthcare providers should address weight management to improve patient satisfaction with diabetes treatment.

Soy isoflavones may be helpful in treating conditions such as insulin resistance, inflammation, cardiovascular disease, and intestinal dysbiosis.

Soy isoflavones could be considered as a potential treatment option for various metabolic conditions associated with PCOS.

CRDs improved hepatic stress (GGT: SMD = -6.08 U/L) and renal function (UACR: SMD = -0.19).

CRDs may be beneficial for improving liver and kidney health in adults.

Gross variability in resistance training outcomes often reflects confounding sources of within-participant variation rather than true inter-individual differences.

Practitioners should be cautious in interpreting variability in training outcomes.

Overfeeding reduced insulin sensitivity more in individuals with short sleep duration compared to those with longer sleep duration.

Encouraging adequate sleep may mitigate negative effects on insulin sensitivity during overeating.

Retatrutide shows additional benefits for metabolic comorbidities such as NASH and cardiovascular disease.

Retatrutide may help manage obesity-related metabolic conditions.

Higher percentage body fat (PBF) is associated with successful weight reduction in both male (OR = 3.990) and female (OR = 2.266) patients.

Monitoring body fat percentage may help predict weight loss success in patients undergoing GLP-1RA treatment.

Surgical treatment of obesity is more effective in treating obesity-associated diseases than conservative treatment.

Surgical options may be prioritized for patients with obesity-related health issues.

Weight re-gain is a common concern after bariatric procedures.

Clinicians should prepare patients for the possibility of weight re-gain and consider revisional surgery options.

Exenatide combined with Metformin improved 2-hour oral glucose tolerance test (OGTT) values by a mean difference of -1.78 (p < 0.001).

The combination therapy may enhance glucose tolerance in women with PCOS.

MRs significantly reduce glycated hemoglobin (HbA1c) levels by 0.24%.

Using meal replacements can lead to better long-term glucose management.

MRs cause a greater decrease in FBS, insulin, and HOMA-IR in individuals over 50 years old compared to those aged 50 years or younger.

Older adults may benefit more from meal replacements in terms of glucose metabolism.

The GTSS group had significantly lower postprandial glucose excursion compared to the standardized breakfast group.

GTSS may provide a more stable postprandial glucose response compared to standard breakfasts.

There is evidence for the association between intake of high-quality carbohydrates and body weight.

Practitioners should encourage the consumption of high-quality carbohydrates for weight management.

Intragastric balloons (IGBs) may improve steatosis and fibrosis in nonalcoholic fatty liver disease and improve quality of life and mental health in the short term.

Practitioners may consider IGBs as a short-term intervention for patients with nonalcoholic fatty liver disease.

Endoscopic sleeve gastroplasty (ESG) may be more effective and durable than intragastric balloons (IGBs) and result in fewer adverse events compared to bariatric surgery.

Practitioners may consider ESG as a preferable option over IGBs and traditional bariatric surgery.

Patients taking GLP-1 RAs had superior nutritional status compared to postbariatric patients, indicated by higher albumin and prealbumin levels.

Improved nutritional status in GLP-1 RA patients may enhance surgical outcomes and recovery.